Overview

Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus

Status:
Completed

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

Pancreatic islets are the part of the pancreas that produce insulin and help control the blood sugar. This study aims to improve islet transplantation as a treatment for Type 1 Diabetes by using a new combination of immunosuppressive drugs that have been successful in treating other autoimmune diseases and in preventing kidney transplant rejection.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

University of California, San Francisco

Collaborator:

Juvenile Diabetes Research Foundation

Treatments:

Abatacept
Immunosuppressive Agents